Virustatic Development Group

Virustatic Ltd:

Robert Hope

EMBA, CA, BSc (Hons)

Virustatic CEO 

Robert is a board level professional, capable of creating and delivering to strategic and operational targets. A proven track record of building high quality relationships and leading large teams. Has succeeded in a number of change environments and has a broad work experience having worked globally and across industry sectors.

Paul Hope

Technical Director and co-founder of Virustatic

Paul joined the Corps of Royal Engineers in 1969 and trained at the Royal School of Military Engineering. In 1986, he invented and patented the MBT Coupler which has been successfully used in high strength reinforced concrete structures worldwide, particularly in earthquake areas where reverse stress is a factor.

Professor Keith Hyde

PhD, FIBMS, CSi, FRCPath Consultant

Clinical Scientist, Emeritus Professor of Haematology & Healthcare Sciences

Professor Valerie Edwards-Jones


Emeritus Professor of Medical Microbiology Visiting Professor, Institute of Skin Integrity and Infection Prevention, University of Huddersfield

Ms Cheryl C Pylypczuk


Former Blood Science Manager for Pathology at Wigan and Salford Royal Foundation Trusts Technical Assessor for Medical Laboratories at UCAS

Dr Alan Green,

Virustatic Commercial Director

Double Honours in Applied Biology & Pure and Applied Chemistry – University of Wales and PhD – University of Aberdeen.

Sally Chong 

Due Diligence; funding

Kieron Brown

Operations Director and Virustatic co-founder

Our scientific partners:

The University of Manchester

Professor Sabine Flitsch

Sabine holds a Chair in Chemical Biology at the University of Manchester in the School of Chemistry. Her research group is housed in the Manchester Interdisciplinary Biocentre (MIB). Sabine graduated from University of Münster in Germany in 1982 with a first class Diploma in Chemistry. She received a Michael Wills scholarship to study for a D.Phil. at the University of Oxford, took up a DAAD Postdoctoral Fellowship at the Massachusetts Institute of Technology (MIT), followed by a lectureship at Oxford in Organic Chemistry for 6 years. Her other career highlights include the Zeneca Research Award in 1996, the Glaxo Wellcome Award for Innovative Chemistry in 1997 and the RSC Interdisciplinary Prize Winner 2014 for her significant contributions in biological chemistry, in particular carbohydrate chemistry and glycobiology.

Dr Samuel Jones

Dame Kathleen Ollerenshaw Fellow in the Department of Materials at the University of Manchester. He heads up the Jones Lab which focuses on understanding material/virus interactions.

Dr Celina Jones

Researcher in fashion product development, quality control, garment technology and textile science and technology including fibre sourcing, fabric construction and finishing, and fabric performance analysis

Dr Alex Casson

Reader in the Materials, Devices and Systems division of the Department of Electrical and Electronic Engineering at the University of Manchester. His research focuses on non-invasive bioelectronics interfaces: the design and application of wearable sensors, and ‘conformal sensors’, for human body monitoring and data analysis from highly artefact prone naturalistic situations.

Dr Richard Blandford

Department of Materials Manchester; Institute of Biotechnology; FSE Research Institutes; National Graphene Institute; FSE Research Institutes.

Protein Technologies Ltd. 

PTL is a biotech company, established in 2010

Dr Farid Khan

Dr Khan is an award-winning scientist and innovator who has worked in drug discovery at GlaxoSmithKline and obtained a PhD from Cambridge University. Dr. Khan has developed drugs for rare diseases, biosensors and imaging agents for cancer diagnosis and treatment. He has formed key interdisciplinary collaborations with industry, academic institutions and charities including stakeholders in the UK’s healthcare agenda.

Dr Tariq Ali

Dr Ali has over 20 years of academic and industrial experience in protein chemistry and molecular biology, with a specific interest and expertise in upstream and downstream protein production. He has been directly involved in the development of biosimilars, ADCs and orphan disease biologics and imaging agents for cancer diagnosis and treatment. Moreover Dr. Ali has experience and expertise in biosensor development, anti-counterfeiting and discovery of new near infra-red fluorescent (NIRF) proteins. He previously held a senior fellowship position at the University of Manchester working on the functional characterisation of molecules associated with the extracellular matrix. This work was more notably related to translational research on developing a biologic targeted for inflammatory conditions specifically a chondroprotective agent for arthritis. He obtained his PhD from the University of Cambridge working on DNA-protein interactions and then moved to the University of Oxford where he was involved with the functional and structural characterisation of specific members of the TGF-beta superfamily of proteins. He also had worked at Cambridge Consultants Ltd working on developing diagnostic probes.

Virustatic Viral Monitor Group

Titan Products

James Barlow – Chairman, Titan Products Limited

Titan Products design, develop and manufacture a wide range of HVAC and BMS integrated solutions. Product range includes; BACnet system controllers, smart environmental sensors, Zigbee wireless sensors, input / output modules and user interfaces.

The Aptamer Group

Joel Sutcliffe – Business Development Executive


Ranald Pringle, Commercial Manager, EMEA

Ranald has been working in commercial roles since 2008 and has experience across a wide range of industries including for multiplex array-based diagnostics and POC devices and advanced materials.